Paradigmia
⌕Sign in ↗
Lessons

Complement pathways (I): lectin pathway

Created by: Alfredo Corell

Here is the outline explained in the previous video. If you have any questions, post them in the comments section at the bottom of the page.


THE LECTIN PATHWAY

The lectin pathway is initiated by soluble receptors that bind to particular carbohydrate structures on the surface of pathogens in order to activate the complement cascade. The alternative pathway recognises pathogen-associated molecular patterns, which are highly repetitive structures found in the cell wall of microorganisms and absent from human cells. Examples are the lipoteichoic acid of Gram-positive bacteria, the lipopolysaccharides of Gram-negative bacteria and the glycans with terminal mannose residues of yeasts.

There are four types of soluble receptor circulating in the blood and body fluids that can recognise carbohydrate patterns on the microbial surface and initiate the pathway:

  • Mannose-binding lectin (MBL): an oligomeric protein synthesised in the liver, made up of a monomer that contains a collagen-like domain at the amino-terminal end and a C-type lectin domain at the carboxy-terminal end. MBL monomers assemble into trimers through the formation of a triple helix in the collagen-like domains. The trimers in turn assemble into oligomers through disulfide bridges between the collagen-like domains. MBL in the blood is composed of between two and six trimers (Figure 11.2). The multimers have a high avidity for structures such as mannose, fucose and N-acetylglucosamine residues of microbes.
  • Ficolins: a group of molecules with a structure and function similar to MBL but which, instead of a lectin-like domain, have a fibrinogen-like domain (Figure 11.2). This allows ficolins to recognise oligosaccharides containing acetylated carbohydrates. Humans synthesise three types of ficolin: ficolin M (ficolin-1), synthesised in the lung and blood cells; and ficolins L (ficolin-2) and H (ficolin-3), synthesised in the liver.

Plasma MBL forms complexes with the serine proteases MASP-1 and MASP-2, which bind to MBL as inactive zymogens. When MBL binds to the surface of a pathogen, a conformational change occurs in MASP-2, which cleaves and activates a second MASP-2 molecule in the same MBL oligomer. Activated MASP-2 is able to cleave the complement components C4 and C2. As with MBL, ficolins assemble into oligomers and form complexes with MASP-1 and MASP-2.

When MASP-2 cleaves C4, C4a and C4b are released. The C4 protein contains a thioester bond that is hidden in its inactive form and exposed in the active form C4b. C4b binds covalently to the cell surface of the microbe by means of the thioester bond, allowing a molecule of C2 to bind. C2 is then cleaved by MASP-2, producing C2b, an active serine protease that remains bound to C4b, forming C4b2b, which is the C3 convertase of the classical and lectin pathways (Figure 11.3).

The C3 convertase (C4b2b) cleaves multiple C3 molecules, producing C3a and C3b. The C3b fragments bind covalently to the surface of the pathogen, and the C3a fragments initiate a local inflammatory response.

The function of MASP-1 has not been fully clarified, but it appears to be able to cleave C3 directly, although less efficiently than C4b2b.

Figure 11.2 Structure of MBL and the ficolins
(Reproduced from Murphy K et al. (2012) Janeway’s Immunobiology (8th Ed.) Garland Science, New York.)
Figure 11.3 The lectin pathway
(Reproduced from Murphy K et al. (2012) Janeway’s Immunobiology (8th Ed.) Garland Science, New York.)
Your study

Select a passage in the lesson. Your highlights are private.

0Back to course →
Keep exploring

Knowledge does not end here.

Paradigmia · YouTube ↗